Literature DB >> 21420949

Tight regulation of p53 activity by Mdm2 is required for ureteric bud growth and branching.

Sylvia Hilliard1, Karam Aboudehen, Xiao Yao, Samir S El-Dahr.   

Abstract

Mdm2 (Murine Double Minute-2) is required to control cellular p53 activity and protein levels. Mdm2 null embryos die of p53-mediated growth arrest and apoptosis at the peri-implantation stage. Thus, the absolute requirement for Mdm2 in organogenesis is unknown. This study examined the role of Mdm2 in kidney development, an organ which develops via epithelial-mesenchymal interactions and branching morphogenesis. Mdm2 mRNA and protein are expressed in the ureteric bud (UB) epithelium and metanephric mesenchyme (MM) lineages. We report here the results of conditional deletion of Mdm2 from the UB epithelium. UB(mdm2-/-) mice die soon after birth and uniformly display severe renal hypodysplasia due to defective UB branching and underdeveloped nephrogenic zone. Ex vivo cultured UB(mdm2-/-) explants exhibit arrested development of the UB and its branches and consequently develop few nephron progenitors. UB(mdm2-/-) cells have reduced proliferation rate and enhanced apoptosis. Although markedly reduced in number, the UB tips of UB(mdm2-/-)metanephroi continue to express c-ret and Wnt11; however, there was a notable reduction in Wnt9b, Lhx-1 and Pax-2 expression levels. We further show that the UB(mdm2-/-) mutant phenotype is mediated by aberrant p53 activity because it is rescued by UB-specific deletion of the p53 gene. These results demonstrate a critical and cell autonomous role for Mdm2 in the UB lineage. Mdm2-mediated inhibition of p53 activity is a prerequisite for renal organogenesis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21420949      PMCID: PMC3086838          DOI: 10.1016/j.ydbio.2011.03.017

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  57 in total

1.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

Review 2.  Glomeruli and blood pressure. Less of one, more the other?

Authors:  B M Brenner; D L Garcia; S Anderson
Journal:  Am J Hypertens       Date:  1988-10       Impact factor: 2.689

3.  Regulation of PTEN transcription by p53.

Authors:  V Stambolic; D MacPherson; D Sas; Y Lin; B Snow; Y Jang; S Benchimol; T W Mak
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

4.  Met and the epidermal growth factor receptor act cooperatively to regulate final nephron number and maintain collecting duct morphology.

Authors:  Shuta Ishibe; Anil Karihaloo; Hong Ma; Junhui Zhang; Arnaud Marlier; Mitchihiro Mitobe; Akashi Togawa; Roland Schmitt; Jan Czyczk; Michael Kashgarian; David S Geller; Snorri S Thorgeirsson; Lloyd G Cantley
Journal:  Development       Date:  2009-01       Impact factor: 6.868

5.  Nephron number in patients with primary hypertension.

Authors:  Gunhild Keller; Gisela Zimmer; Gerhard Mall; Eberhard Ritz; Kerstin Amann
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

6.  Regulation of p53: intricate loops and delicate balances.

Authors:  Moshe Oren; Alexander Damalas; Tanya Gottlieb; Dan Michael; Jan Taplick; Juan Fernando Martinez Leal; Ruth Maya; Miri Moas; Rony Seger; Yoichi Taya; Avri Ben-Ze'ev
Journal:  Biochem Pharmacol       Date:  2002-09       Impact factor: 5.858

Review 7.  The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network.

Authors:  Lindsey D Mayo; David B Donner
Journal:  Trends Biochem Sci       Date:  2002-09       Impact factor: 13.807

8.  Switching mechanisms of cell death in mdm2- and mdm4-null mice by deletion of p53 downstream targets.

Authors:  Arturo Chavez-Reyes; John M Parant; Lisa L Amelse; Roberto Montes de Oca Luna; Stanley J Korsmeyer; Guillermina Lozano
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

9.  mdm2 Is critical for inhibition of p53 during lymphopoiesis and the response to ionizing irradiation.

Authors:  Susan M Mendrysa; Matthew K McElwee; Jennifer Michalowski; Kathleen A O'Leary; Karen M Young; Mary Ellen Perry
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

10.  Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line.

Authors:  S S Fakharzadeh; S P Trusko; D L George
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

View more
  20 in total

1.  Mechanisms of p53 activation and physiological relevance in the developing kidney.

Authors:  Karam Aboudehen; Sylvia Hilliard; Zubaida Saifudeen; Samir S El-Dahr
Journal:  Am J Physiol Renal Physiol       Date:  2012-01-11

Review 2.  Histone deacetylases in kidney development: implications for disease and therapy.

Authors:  Shaowei Chen; Samir S El-Dahr
Journal:  Pediatr Nephrol       Date:  2012-06-22       Impact factor: 3.714

3.  Aberrant activation of p53 due to loss of MDM2 or MDMX causes early lens dysmorphogenesis.

Authors:  Yiwei Zhang; Xin Zhang; Hua Lu
Journal:  Dev Biol       Date:  2014-09-28       Impact factor: 3.582

4.  Disruption of Robo2-Baiap2 integrated signaling drives cystic disease.

Authors:  Qinggang Li; Shaoyuan Cui; Qian Ma; Ying Liu; Hongyu Yu; GuangRui Geng; Ewud Agborbesong; Chongyu Ren; Kai Wei; Yingjie Zhang; Jurong Yang; Xueyuan Bai; Guangyan Cai; Yuansheng Xie; Xiaogang Li; Xiangmei Chen
Journal:  JCI Insight       Date:  2019-09-19

5.  Histone deacetylase 1 and 2 regulate Wnt and p53 pathways in the ureteric bud epithelium.

Authors:  Shaowei Chen; Xiao Yao; Yuwen Li; Zubaida Saifudeen; Dimcho Bachvarov; Samir S El-Dahr
Journal:  Development       Date:  2015-03-15       Impact factor: 6.868

6.  Mdm2 is required for maintenance of the nephrogenic niche.

Authors:  Sylvia A Hilliard; Xiao Yao; Samir S El-Dahr
Journal:  Dev Biol       Date:  2014-01-17       Impact factor: 3.582

7.  Tissue-specific and age-dependent effects of global Mdm2 loss.

Authors:  Yun Zhang; Shunbin Xiong; Qin Li; Sophia Hu; Mehrnoosh Tashakori; Carolyn Van Pelt; Mingjian James You; Laura Pageon; Guillermina Lozano
Journal:  J Pathol       Date:  2014-06-09       Impact factor: 7.996

Review 8.  The MDM2-p53 pathway: multiple roles in kidney development.

Authors:  Samir El-Dahr; Sylvia Hilliard; Karam Aboudehen; Zubaida Saifudeen
Journal:  Pediatr Nephrol       Date:  2014-04       Impact factor: 3.714

9.  Monitoring p53 by MDM2 and MDMX is required for endocrine pancreas development and function in a spatio-temporal manner.

Authors:  Yiwei Zhang; Shelya X Zeng; Qian Hao; Hua Lu
Journal:  Dev Biol       Date:  2017-01-22       Impact factor: 3.582

10.  AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity.

Authors:  Guifen He; Yi-Wei Zhang; Jun-Ho Lee; Shelya X Zeng; Yunyuan V Wang; Zhijun Luo; X Charlie Dong; Benoit Viollet; Geoffrey M Wahl; Hua Lu
Journal:  Mol Cell Biol       Date:  2013-11-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.